Novel Pharmacotherapy in Hypertrophic Cardiomyopathy
This article reviews the currently recommended and frequently used medications (beta-blockers, nondihydropyridine calcium channel blockers, and disopyramide) and emerging pharmacological treatment options in the management of HCM. The mechanism of action and latest clinical trials of the novel agents are discussed in greater detail.
Source: Cardiology in Review - Category: Cardiology Tags: Review Articles Source Type: research
More News: Beta-Blockers | Calcium | Cardiology | Cardiomyopathy | Clinical Trials | Genetics | Heart | Heart Failure | Hypertrophic Cardiomyopathy